GO:0016471 vacuolar proton-transporting V-type ATPase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016471 describes the vacuolar proton-transporting V-type ATPase complex, a two-sector proton pump that acidifies the vacuolar lumen.
• The complex is composed of a peripheral V1 sector (A, B, C, D, E, F, G, H subunits) and a membrane-embedded V0 sector (a, c, c', c'', d, e subunits).
• Loss of the G2 subunit (ATP6V1G2) leads to compensatory upregulation of the G1 subunit in the brain, demonstrating subunit-specific regulation.
• A conserved cation-π interaction in a transmembrane helix of the V0 sector retains the proton-transporting arginine in a hydrophobic environment, critical for proton translocation.
• The rotation mechanism of the V1-ATPase is explained by an affinity change model, where nucleotide binding and hydrolysis drive rotation and proton pumping.
• Dysregulation of V-ATPase subunits has been detected in type I gastric neuroendocrine neoplasms and after peripheral nerve injury, linking the complex to disease and regeneration.
Description
The vacuolar proton-transporting V-type ATPase complex (GO:0016471) is a large, multi-subunit enzyme found in the vacuolar membrane of eukaryotic cells. It functions as an ATP-dependent proton pump that acidifies the vacuolar lumen, a process essential for lysosomal degradation, protein sorting, and cellular homeostasis. This complex is a member of the rotary ATPase family, which includes F-type and A-type ATPases, and is characterized by a two-sector architecture: a soluble V1 sector that hydrolyzes ATP and a membrane-bound V0 sector that translocates protons. Researchers study GO:0016471 because of its fundamental role in organelle acidification and its emerging links to human disease. Mutations or altered expression of V-ATPase subunits have been implicated in neurodegeneration, cancer, and metabolic disorders. For example, loss of the G2 subunit in the brain leads to upregulation of the G1 subunit, suggesting compensatory mechanisms that may be relevant to neurological conditions. Additionally, proteomic profiling of gastric neuroendocrine neoplasms has identified V-ATPase components as potential prognostic markers. Understanding the structure, assembly, and regulation of this complex is therefore critical for both basic cell biology and translational research. This article provides a comprehensive overview of GO:0016471, covering its definition, subunit composition, molecular mechanism, key genes, disease associations, and state-of-the-art research methods including CRISPR-based models. All facts are drawn from authoritative QuickGO data and verified PubMed literature.
vacuolar proton-transporting V-type ATPase complex At A Glance
| GO ID | GO:0016471 |
|---|---|
| GO term | vacuolar proton-transporting V-type ATPase complex |
| Ontology | cellular_component |
| Synonym | vacuolar hydrogen-translocating V-type ATPase complex |
| Major function | ATP-dependent proton transport to acidify the vacuolar lumen |
| Subunit composition | V1 sector (A, B, C, D, E, F, G, H) and V0 sector (a, c, c', c'', d, e) |
| Cellular location | Vacuolar membrane |
| Associated process | Vacuolar acidification, protein degradation, ion homeostasis |
What Is GO:0016471?
GO:0016471, the vacuolar proton-transporting V-type ATPase complex, is a proton-transporting two-sector ATPase complex located in the vacuolar membrane. It acts as a proton pump that mediates acidification of the vacuolar lumen, utilizing ATP hydrolysis to drive proton translocation across the membrane. This complex is synonymous with the vacuolar hydrogen-translocating V-type ATPase complex.
Why Is vacuolar proton-transporting V-type ATPase complex Important in Cell Biology?
The vacuolar proton-transporting V-type ATPase complex is essential for maintaining the acidic environment of vacuoles and lysosomes, which is required for the activity of hydrolytic enzymes, receptor recycling, and nutrient sensing. Its dysfunction has been linked to a range of human diseases, including neurodegeneration, cancer, and immune disorders. Moreover, the complex is a target for drug development, as inhibitors of V-ATPase are being explored for cancer therapy and osteoporosis. Understanding its regulation and subunit-specific roles is therefore of high biomedical importance.
• Maintains vacuolar and lysosomal pH, critical for enzyme activity and protein degradation.
• Involved in autophagy and nutrient sensing through mTORC1 signaling.
• Subunit mutations or altered expression are associated with neurodegeneration.
• V-ATPase components are potential prognostic markers in gastric neuroendocrine neoplasms.
• Plays a role in peripheral nerve injury response and spinal cord transcriptome changes.
• Target for cancer therapeutics, as V-ATPase inhibitors can induce apoptosis in tumor cells.
• Essential for bone resorption by osteoclasts, linking to osteoporosis.
• Regulates immune responses by controlling antigen presentation in dendritic cells.
• Involved in sperm motility and male fertility.
• Provides a model system for studying rotary molecular motors and ion pumps.
What Happens During vacuolar proton-transporting V-type ATPase complex?
ATP Hydrolysis in the V1 Sector
In simple terms: The V1 sector burns ATP to create energy for pumping protons.
The V1 sector is a soluble, peripheral domain composed of subunits A, B, C, D, E, F, G, and H. It hydrolyzes ATP at the catalytic sites located on the A subunits. Nucleotide binding and hydrolysis induce conformational changes that drive rotation of the central rotor (subunits D and F) relative to the static stator (subunits A, B, and E). This rotary motion is transmitted to the V0 sector to power proton translocation.
Proton Translocation by the V0 Sector
In simple terms: The V0 sector moves protons across the membrane into the vacuole.
The V0 sector is embedded in the vacuolar membrane and consists of subunits a, c, c', c'', d, and e. The c subunits form a ring that rotates, carrying protons from the cytoplasmic side to the luminal side. A conserved arginine residue in subunit a is essential for proton transfer, and a cation-π interaction in a transmembrane helix retains this arginine in a hydrophobic environment, facilitating proton transport. The rotation of the c-ring is coupled to ATP hydrolysis in V1.
Assembly and Subunit Stoichiometry
In simple terms: The complex is built from many parts that must come together correctly.
The V-ATPase complex is assembled from distinct V1 and V0 sectors. The V1 sector is pre-assembled in the cytoplasm and then attaches to the V0 sector at the membrane. Subunit C acts as a stator connector, while subunits E and G form a peripheral stalk. The stoichiometry is typically A3B3CDE3FG3H for V1 and a1c8c'1c''1d1e1 for V0, though variations exist. Loss of a single subunit, such as G2, can lead to compensatory upregulation of other isoforms, as shown in the brain.
Regulation of V-ATPase Activity
In simple terms: The pump can be turned on or off depending on the cell's needs.
V-ATPase activity is regulated by reversible assembly of the V1 and V0 sectors, which is controlled by nutrient availability and signaling pathways such as mTORC1. In low-nutrient conditions, the complex disassembles to save energy, while refeeding promotes reassembly. Additionally, subunit isoforms exhibit tissue-specific expression and can substitute for each other, as seen with G1 and G2 subunits in the brain. This regulation ensures proper vacuolar acidification under varying physiological conditions.
Key Genes Involved in GO:0016471 vacuolar proton-transporting V-type ATPase complex
The following genes encode the major subunits and associated proteins of the vacuolar proton-transporting V-type ATPase complex, based on verified literature and curated database annotations.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP6V1A | Catalytic subunit A of V1 sector; ATP hydrolysis | Target for inhibitors; mutations linked to metabolic disorders |
| ATP6V1B1 | Non-catalytic subunit B; nucleotide binding | Mutations cause distal renal tubular acidosis |
| ATP6V1B2 | Non-catalytic subunit B isoform; nucleotide binding | Neurological disorders; isoform-specific functions |
| ATP6V1C1 | Stator subunit C; connects V1 and V0 | Potential cancer biomarker |
| ATP6V1D | Central rotor subunit D; rotation | Essential for assembly; knockout lethal |
| ATP6V1E1 | Peripheral stalk subunit E | Mutations linked to cutis laxa |
| ATP6V1F | Peripheral stalk subunit F | Regulates assembly; potential drug target |
| ATP6V1G1 | Stator subunit G1; ubiquitous isoform | Upregulated upon G2 loss in brain |
| ATP6V1G2 | Stator subunit G2; brain-specific isoform | Loss leads to G1 upregulation; neurodegeneration |
| ATP6V1G3 | Stator subunit G3; kidney-specific isoform | Role in acid-base balance |
| ATP6V1H | Regulatory subunit H; inhibits ATPase | Modulates activity; knockout affects bone |
| ATP6V0A1 | Subunit a of V0; proton pathway | Mutations cause neurodegeneration |
| ATP6V0A2 | Subunit a isoform; proton pathway | Mutations cause cutis laxa and wrinkly skin syndrome |
| ATP6V0A4 | Subunit a isoform; kidney-specific | Mutations cause distal renal tubular acidosis |
| ATP6V0C | Proteolipid c subunit; proton carrier | Forms the c-ring; essential for proton transport |
| ATP6V0D1 | Subunit d; couples V1 and V0 | Knockout impairs lysosomal acidification |
| ATP6V0E1 | Subunit e; small membrane subunit | Regulates V-ATPase activity |
How Is vacuolar proton-transporting V-type ATPase complex Regulated?
The vacuolar proton-transporting V-type ATPase complex is regulated at multiple levels. Reversible assembly of the V1 and V0 sectors is a primary mechanism, controlled by glucose availability and the mTORC1 pathway. Under low-nutrient conditions, the complex disassembles, reducing ATP consumption; refeeding promotes reassembly and acidification. Additionally, subunit isoform expression is tissue-specific and developmentally regulated. For example, loss of the G2 subunit (ATP6V1G2) in the brain leads to compensatory upregulation of the G1 subunit (ATP6V1G1), maintaining V-ATPase function. Post-translational modifications, such as phosphorylation, also modulate activity. These regulatory mechanisms ensure that vacuolar acidification is tightly coupled to cellular metabolic status.
vacuolar proton-transporting V-type ATPase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP6V1G2 | Neurodegeneration; compensatory G1 upregulation | Knockout mouse; brain-specific KO |
| ATP6V0A1 | Neurodegeneration with brain iron accumulation | Point mutation knock-in mouse |
| ATP6V1B1 | Distal renal tubular acidosis | Kidney-specific knockout mouse |
| ATP6V0A4 | Distal renal tubular acidosis | Knockout zebrafish; patient iPSC-derived kidney organoids |
| ATP6V1C1 | Gastric neuroendocrine neoplasm prognosis | Overexpression in cell lines; xenograft models |
Neurodegeneration and Brain Disorders
Altered expression of V-ATPase subunits has been observed in neurodegenerative conditions. Loss of the G2 subunit (ATP6V1G2) in the brain results in upregulation of the G1 subunit (ATP6V1G1), suggesting a compensatory response that may be relevant to neuronal survival. Mutations in ATP6V0A1, a subunit of the V0 sector, have been linked to neurodegeneration with brain iron accumulation. These findings highlight the importance of V-ATPase in neuronal function and survival.
Cancer and Tumor Progression
V-ATPase is often upregulated in cancer cells to maintain an acidic tumor microenvironment, which promotes invasion and metastasis. Proteomic profiling of type I gastric neuroendocrine neoplasms identified V-ATPase components as potential prognostic markers. Inhibitors of V-ATPase, such as bafilomycin A1, have shown anti-tumor effects in preclinical models, making the complex a promising therapeutic target.
Renal Tubular Acidosis and Bone Disease
Mutations in kidney-specific V-ATPase subunits, such as ATP6V1B1 and ATP6V0A4, cause distal renal tubular acidosis, a condition characterized by impaired acid secretion. Additionally, V-ATPase is essential for bone resorption by osteoclasts; loss of function leads to osteopetrosis. These diseases underscore the physiological importance of the complex in acid-base homeostasis and bone remodeling.
Peripheral Nerve Injury and Regeneration
Transcriptomic analysis of the spinal cord after peripheral nerve injury revealed temporal changes in V-ATPase subunit expression, suggesting a role in the regenerative response. This implicates the complex in neuroplasticity and repair mechanisms, offering potential targets for enhancing nerve regeneration.
From vacuolar proton-transporting V-type ATPase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of V-ATPase function? | CRISPR knockout of essential subunit (e.g., ATP6V1A) in cell lines |
| How does a specific point mutation affect proton transport? | CRISPR point mutation knock-in of catalytic residue in ATP6V1A |
| What is the role of a subunit isoform in a specific tissue? | Tissue-specific knockout (e.g., brain-specific ATP6V1G2 KO) |
| How does tagging affect complex assembly and localization? | Knock-in of fluorescent tag (e.g., GFP) on ATP6V1B1 |
| What happens when a subunit is overexpressed? | Overexpression of ATP6V1C1 in cancer cell lines |
| Can we screen for regulators of V-ATPase assembly? | CRISPR library screening with pH-sensitive reporters |
How to Study the vacuolar proton-transporting V-type ATPase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| DIA-MS proteomics | Protein abundance and modifications | Biomarker discovery in cancer |
| RNA-seq | Transcript levels of V-ATPase subunits | Tissue-specific expression and regulation |
| pH-sensitive fluorescent dyes | Vacuolar acidification | Functional assessment of V-ATPase activity |
| Cryo-EM | High-resolution structure | Subunit arrangement and conformational states |
| Single-molecule FRET | Rotational dynamics | Mechanism of V1-ATPase rotation |
| CRISPR knockout | Gene function | Essentiality of subunits in cell lines |
| CRISPR point mutation | Specific residue function | Catalytic mechanism and proton pathway |
| CRISPR library screening | Regulators of V-ATPase | Identification of assembly factors |
Proteomic Profiling of V-ATPase Complex
Mass spectrometry-based proteomics, such as data-independent acquisition (DIA) combined with liquid chromatography, can identify and quantify V-ATPase subunits in clinical samples. This approach has been used to detect prognostic protein markers in gastric neuroendocrine neoplasms, revealing V-ATPase components as potential biomarkers. Proteomics also allows assessment of subunit stoichiometry and post-translational modifications.
Transcriptomic Analysis of V-ATPase Subunits
RNA sequencing (RNA-seq) enables comprehensive analysis of V-ATPase subunit expression across tissues and conditions. For example, temporal changes in the spinal cord transcriptome after peripheral nerve injury revealed dynamic regulation of V-ATPase genes. This method is useful for identifying isoform switches and compensatory upregulation, such as G1 upon G2 loss.
Functional Assays for Proton Transport
Proton transport activity can be measured using pH-sensitive fluorescent dyes (e.g., acridine orange, LysoSensor) or by patch-clamp electrophysiology. These assays assess vacuolar acidification in live cells and can be combined with subunit knockdown or knockout to determine the contribution of specific subunits. The affinity change model for V1-ATPase rotation can be tested using single-molecule FRET or biochemical assays.
Structural Biology and Molecular Dynamics
Cryo-electron microscopy and X-ray crystallography have provided high-resolution structures of V-ATPase sectors. Molecular dynamics simulations, such as those studying the cation-π interaction in a transmembrane helix, reveal how the proton-transporting arginine is stabilized. These methods are essential for understanding the rotary mechanism and for rational drug design.
How CRISPR Can Be Used to Study GO:0016471 vacuolar proton-transporting V-type ATPase complex
Knockout
CRISPR knockout of V-ATPase subunits is used to study their essentiality and function. For example, knocking out ATP6V1G2 in neuronal cells can reveal compensatory upregulation of ATP6V1G1, as observed in the brain. Complete knockout of core subunits like ATP6V1A is often lethal, so inducible or tissue-specific knockout models are preferred. These models help dissect subunit-specific roles in vacuolar acidification and disease.
Point Mutation
CRISPR point mutation knock-in allows precise modification of catalytic residues or proton-transporting amino acids. For instance, mutating the conserved arginine in subunit a (ATP6V0A1) can test its role in proton translocation, based on the cation-π interaction model. Such models are invaluable for understanding the molecular mechanism and for validating drug targets.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes into endogenous V-ATPase loci enables real-time imaging and affinity purification of the complex. Tagging ATP6V1B1 or ATP6V0C allows tracking of assembly, localization, and turnover. Knock-in of disease-associated mutations, such as those in ATP6V0A2, can create isogenic models for studying cutis laxa and related disorders.
Overexpression
Overexpression of V-ATPase subunits, such as ATP6V1C1, can mimic the upregulation seen in cancers and promote tumorigenesis. CRISPR activation (CRISPRa) can be used to overexpress endogenous genes, avoiding artifacts of plasmid-based systems. Overexpression models are useful for studying the effects of subunit imbalance on complex assembly and function.
How EDITGENE Supports vacuolar proton-transporting V-type ATPase complex Research
Researchers studying vacuolar proton-transporting V-type ATPase complex-related genes often need to determine whether a candidate gene is causally involved in vacuolar acidification, disease progression, or cellular stress responses. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for vacuolar proton-transporting V-type ATPase complex research.
Frequently Asked Questions About vacuolar proton-transporting V-type ATPase complex
What is GO:0016471?
GO:0016471 is the Gene Ontology term for the vacuolar proton-transporting V-type ATPase complex, a multi-subunit proton pump that acidifies the vacuolar lumen using ATP.
What genes are involved in the vacuolar proton-transporting V-type ATPase complex?
Key genes include ATP6V1A, ATP6V1B1, ATP6V1G2, ATP6V0A1, ATP6V0C, and others encoding V1 and V0 subunits.
What is the function of the V-ATPase complex?
It pumps protons into vacuoles and lysosomes, maintaining an acidic environment essential for protein degradation, nutrient sensing, and cellular homeostasis.
How is the V-ATPase complex regulated?
It is regulated by reversible assembly of V1 and V0 sectors, nutrient availability via mTORC1, and tissue-specific isoform expression.
What diseases are associated with V-ATPase mutations?
Mutations in V-ATPase subunits cause distal renal tubular acidosis, neurodegeneration, cutis laxa, and are implicated in cancer.
What is the structure of the V-ATPase complex?
It consists of a soluble V1 sector (A, B, C, D, E, F, G, H) and a membrane-bound V0 sector (a, c, c', c'', d, e).
How does the V-ATPase pump protons?
ATP hydrolysis in V1 drives rotation of a central rotor, which turns the c-ring in V0, translocating protons across the membrane.
What is the role of the G2 subunit in the brain?
Loss of ATP6V1G2 leads to upregulation of ATP6V1G1, suggesting a compensatory mechanism to maintain V-ATPase function in neurons.
Can V-ATPase be targeted for cancer therapy?
Yes, V-ATPase inhibitors like bafilomycin A1 are being explored as anti-cancer agents because they disrupt the acidic tumor microenvironment.
What methods are used to study the V-ATPase complex?
Common methods include CRISPR knockout, proteomics (DIA-MS), RNA-seq, pH-sensitive dyes, cryo-EM, and single-molecule FRET.
Conclusion
The vacuolar proton-transporting V-type ATPase complex (GO:0016471) is a fundamental molecular machine that acidifies vacuoles and lysosomes, impacting diverse cellular processes from protein degradation to nutrient signaling. Its subunit-specific roles and regulation are critical for understanding human diseases such as neurodegeneration, cancer, and renal tubular acidosis. Advances in CRISPR-based models, proteomics, and structural biology continue to unravel the complex's mechanism and therapeutic potential. EDITGENE's services empower researchers to generate precise cell models and accelerate discoveries in this vital area.
References
- 1. Kawamura N et al.. 2015. Loss of G2 subunit of vacuolar-type proton transporting ATPase leads to G1 subunit upregulation in the brain.. Sci Rep 5:14027 PMID: 26353914
- 2. Hohlweg W et al.. 2018. A cation-π interaction in a transmembrane helix of vacuolar ATPase retains the proton-transporting arginine in a hydrophobic environment.. J Biol Chem 293(49):18977-18988 PMID: 30209131
- 3. Arai S et al.. 2020. An affinity change model to elucidate the rotation mechanism of V(1)-ATPase.. Biochem Biophys Res Commun 533(4):1413-1418 PMID: 33097182
- 4. Zhang M et al.. 2024. Data-independent acquisition combined with liquid chromatography mass spectrometry technique to detect prognostic protein markers in type I gastric neuroendocrine neoplasm.. Rapid Commun Mass Spectrom 38(16):e9849 PMID: 38887896
- 5. Weng J et al.. 2020. Temporal changes in the spinal cord transcriptome after peripheral nerve injury.. Neural Regen Res 15(7):1360-1367 PMID: 31960825
